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Editorial Summary: This protocol describes how to perform CUBIC (Clear, 1 
Unobstructed Brain/Body Imaging Cocktails and Computational analysis), a simple and 2 
efficient method for organ clearing, imaging by light-sheet microscopy, and quantitative 3 
imaging analysis.  4 
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Abstract/summary 1 
Here we describe a protocol for advanced CUBIC (Clear, Unobstructed Brain/Body 2 
Imaging Cocktails and Computational analysis). The CUBIC protocol enables simple 3 
and efficient organ clearing, rapid imaging by light-sheet microscopy, and quantitative 4 
imaging analysis of multiple samples. The organ/body is cleared by immersion for 1-14 5 
d, with the exact time required dependent on sample type and experimental purposes. A 6 
single set of imaging can be completed in 30-60 min. Image processing and analysis 7 
can take less than 1 d but is dependent on the number of samples in the dataset. The 8 
CUBIC clearing protocol can process multiple samples simultaneously. We previously 9 
used CUBIC to image whole-brain neural activities at single-cell resolution using 10 
Arc-dVenus transgenic (Tg) mice. CUBIC informatics calculated the Venus signal 11 
subtraction, comparing different brains at a whole-organ scale. These protocols provide 12 
a platform for organism-level systems biology by comprehensively detecting cells in a 13 
whole organ or body. 14 
(149 words) 15 
  16 
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INTRODUCTION 1 
Since the discovery of the ‘cell’ as the basic unit of living organisms, people have been 2 
seeking a way to observe all cells inside the body. Comprehensive analysis of cells in 3 
organs and whole organisms is expected to provide information about type, position, 4 
number and activity of cells and cellular networks. Tissue clearing followed by 5 
three-dimensional (3D) imaging is one approach that enables the analysis of multiple 6 
cells simultaneously in organs. Thus development of this and related technologies has 7 
become a recent trend1, 2.  8 
 9 
Development of tissue clearing methods 10 
Early tissue clearing methods used organic chemicals (e.g. Benzyl alcohol-methyl 11 
salicylate, BABB, 3DISCO) for this purpose3-6. Some of these methods achieved high 12 
transparency within a few days by removing lipids and homogenizing refractive indices 13 
(RI) of the tissue and were shown to be compatible with whole-mount 14 
immunohistochemical analysis7. However, concerns about the quenching of fluorescent 15 
proteins and safety issues led to further method development. Very recent publication 16 
addressed this issue, reporting that pH control and temperature during clearing are the 17 
critical points to stabilize fluorescent proteins8. Alternative techniques, such as Scale9, 18 
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use a hydrophilic chemical urea, and more recently developed tissue clearing methods 1 
use other hydrophilic reagents, including SeeDB10, ClearT11, or 2,2'-thiodiethanol12, 13 2 
and FRUIT14. These methods are easy, safe, and fluorescent signals are retained 3 
however have relatively low clearing capability. The introduction of CLARITY enabled 4 
both the fluorescence retention and high transparency by embedding a tissue into 5 
hydrogel polymer and removing most of the lipids by electrophoresis15. Possible 6 
drawbacks of CLARITY included its technical difficulty and the limited scalability due to 7 
the need to use a specific device. However, these difficulties have been addressed by 8 
the development of passive clearing protocols that increased the scalability16, 17. 9 
In this protocol we describe how to perform CUBIC. CUBIC offers a 10 
high-performance and device-free tissue clearing method that preserves fluorescence 11 
based on hydrophilic reagents. It enables reproducible whole-organ and whole-body 12 
clearing. We have used CUBIC for clearing and rapid 3D imaging of whole mouse 13 
brains, a whole marmoset hemisphere, whole mouse organs (e.g. lung and heart) and 14 
whole mouse body. These images were used for image analyses for extracting 15 
biological information18, 19. 16 
 17 
Methods to image cleared tissues 18 
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Tissues cleared using the above methods can be imaged in 3D with optical 1 
microscopies. Because some of the above clearing methods render tissues highly 2 
transparent, light-sheet fluorescence microscopy (LSFM) has also been used for 3 
imaging1, 2. This type of microscopy can collect Z-stack images in a rapid manner and 4 
has been applied to 3D and 4D imaging, such as a time-lapse imaging of developing 5 
embryos or whole-brain calcium dynamics20-23. One of the earliest cases of whole 6 
mouse brain imaging was rapid whole-brain imaging of a BABB-cleared brain using a 7 
macrozoom-compatible light-sheet unit (Ultramicroscopy)4. More recently, COLM 8 
(CLARITY-optimized light-sheet microscopy) has been used for whole brain-scale 9 
imaging of CLARITY-processed brains16. Thus LSFM after an efficient tissue clearing 10 
method facilitates a high-throughput collection of multiple 3D images. 11 
Rapid 3D imaging with LSFM can be used following whole-organ and 12 
whole-body clearing by CUBIC. CUBIC also provides processing and analysis of 3D 13 
images for extracting biological information. Therefore, CUBIC presents a platform of 14 
whole-organ/body imaging and image informatics, which enables a wide range of users 15 
to perform experiments targeting cellular and organ layers with multiple samples. 16 
 17 
Development of CUBIC for efficient and reproducible whole-organ/body clearing  18 
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In developing a clearing technique for whole-brain and whole-body imaging we 1 
considered two main criteria, one, efficiency and transparency, and preservation of 2 
fluorescence for a rapid whole-brain/body imaging with LSFM, and two, reproducibility 3 
for comparative analysis of multiple samples. Because a clearing method with 4 
hydrophilic reagents had the potential to fulfill these criteria, we started by modifying the 5 
Scale recipe9. For this purpose, we constructed a new chemical screening method in 6 
which reduction of turbidity of a fixed-brain suspension was measured before and after 7 
mixing with a candidate chemical solution18. This screening enables non-biased 8 
discovery of brain clearing chemicals. We screened 40 Scale-related chemicals and 9 
found that aminoalcohols, in addition to urea and Triton X-100 in Scale, clear tissue with 10 
minimal fluorescent quenching18. In the CUBIC clearing protocol, we prepared two 11 
reagents ScaleCUBIC-1 (reagent-1) and ScaleCUBIC-2 (reagent-2) which also 12 
minimize light scattering inside the tissue. The first reagent works as a potential lipid 13 
remover. Lipid is thought to be the main light-scattering material inside tissue and its 14 
removal is correlated with the degree of transparency. A fixed brain was treated with the 15 
first reagent for about one week, washed with buffer and then immersed into the second 16 
reagent which has an RI close to ~1.49, similar to that of the SeeDB reagent10. Moving 17 
from buffer to the second reagent matched RIs between sample and reagent, which 18 
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further reduced light scattering within the tissue. Thus, a whole mouse brain became 1 
transparent within ~14 d18. However, some chemicals seem to have additional or 2 
different roles during the procedure, and thus further studies are needed to elucidate 3 
tissue-clearing mechanisms. 4 
In addition to light scattering, light absorption is another challenge in tissue 5 
clearing. We accidentally found that aminoalcohols can remove heme in blood and 6 
tissues19, thus CUBIC is able to decolorize tissue. Perfusion of the CUBIC reagent 7 
(CB-Perfusion) was used to efficiently penetrate the mouse body and to accelerate the 8 
clearing and decoloring procedure. The CB-Perfusion protocol enabled not only faster 9 
clearing of dissected tissues, but also whole-body clearing of infant and adult mice19. 10 
Because of its efficiency and reproducibility, the CUBIC protocol can be applied 11 
to multiple samples in a single experiment, and is scalable from subcellular structures 12 
(e.g. neuronal axons or spines) to marmoset brains to whole animal bodies18, 19. 13 
Furthermore, whole-organ counterstaining with a nucleic dye enables precise 14 
positioning of genetically labeled cells in the whole-organ structure, extraction of 15 
specific anatomical structures, and alignment of different samples for comparing signal 16 
intensities18, 19.  17 
 18 
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CUBIC for whole-organ/body imaging and image informatics 1 
CUBIC-cleared samples can be used in LSFM. We use an optimized Ultramicroscope 2 
(LaVision BioTec) for this purpose. In rapid whole-organ imaging, a single, cleared, 3 
whole mouse brain can be imaged within 30-60 min per color and orientation. 4 
Fluorescence wavelength affects the quality of imaging results; in general, red 5 
wavelengths can penetrate deeper in tissue and thus better imaging results are 6 
obtained with red fluorescence than green fluorescence, particularly in deeper regions. 7 
To ensure weaker signals are detected in deeper regions, the sample is imaged in two 8 
orientations; in the case of whole-brain imaging, we took Z-stack images of dorsal side 9 
up (D-V) and ventral side up (V-D) directions. 10 
Image visualization software such as Imaris can be used for depicting the 11 
reconstituted 3D image. Imaris implements numerous image analysis functions 12 
including spot counting and surface extraction. We performed extractions of anatomical 13 
structures in the 3D images for comparison of Langerhans islets in normal and diabetic 14 
pancreases, for example19. For more complicated analyses, we implemented image 15 
informatics often used in functional magnetic resonance image (fMRI) analysis18. First, 16 
structural images via counterstaining were registered to a reference brain to calculate 17 
transformation parameters. Then, the transformation parameters were applied to the 18 
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corresponding signal images (transgenes etc.) for alignment. These aligned images 1 
could be merged with each other to calculate signal subtraction between samples. This 2 
analysis was performed with open-source software such as Advanced Normalization 3 
Tools (ANTS)24 and ITK-SNAP25 but requires advanced informatics and computer 4 
science skills. For the user’s convenience, we provide an easier analysis pipeline with 5 
prepared scripts in this manuscript (see below). As an example of the comparative 6 
analysis, we demonstrate 3D image analysis of Arc-dVenus Tg mouse brains with or 7 
without light stimulation and calculate the signal subtraction18, 26. The final subtraction 8 
data clearly depicts regions and cells in the whole brain where neurons responded to 9 
the light stimuli. Such direct comparative analysis by using whole-brain fluorescent 3D 10 
images was first reported using CUBIC informatics18. CUBIC informatics enables 11 
quantitative identification of stimulus- or timing-dependent neural activities and will help 12 
delineate structural abnormalities in disease samples at the whole-organ and 13 
whole-body scale. 14 
 15 
Overview of CUBIC pipeline  16 
CUBIC provides a platform for a comprehensive analysis of cells in a whole organ or 17 
body. Here we focus on describing: 1) the advanced CUBIC clearing protocols by 18 
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simple immersion and CB-Perfusion (steps 1-2); 2) whole-brain and -organ imaging with 1 
a LSFM (steps 3-6); and 3) CUBIC informatics for preprocessing and comparison of 2 
different brain samples (steps 7-15, see also Fig. 1). Although CUBIC is also applicable 3 
to staining with small chemicals or antibodies over days to weeks, as described 4 
previously18, 19, we focus here on imaging of fluorescent proteins together with nuclear 5 
counterstaining. 6 
Tissue clearing. Here we provide three clearing procedures: step 2 option A) simple 7 
immersion protocol for dissected whole organs; step 2 option B) CB-Perfusion and 8 
immersion protocol for faster clearing of whole organs; and step 2 option C) 9 
CB-Perfusion protocol for whole-body clearing. The immersion protocol in our first 10 
CUBIC report18 has been improved to an advanced version (Fig. 2), in which the 11 
clearing speed and efficiency are increased. The CB-Perfusion protocol (Fig. 3) is 12 
almost identical to our second CUBIC report19 but more detail is given in this manuscript. 13 
The clearing performance of CB-perfusion surpasses the immersion protocol, 14 
particularly in heme-rich organs (heart, muscle, kidney, or liver)19 but tends to cause 15 
decreased signal intensity due to a short fixation time. Incubation period can be varied 16 
and is dependent on the organ and imaging methods to be used (Fig. 1-3). Users may 17 
select either of these options and determine the desired final transparency for their 18 
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experimental purposes. In either option, a paraformaldehyde (PFA) fixation is needed. 1 
Thus animals are transcardially perfused with 4% (wt/vol) PFA and then organs are 2 
dissected for post-fixation (step 1). Alternatively the fixed body can be further perfused 3 
with diluted reagent-1. Samples are subsequently treated with reagent-1 and reagent-2. 4 
Counterstaining is performed during and after reagent-1 treatment18, 19. Samples can be 5 
stored at various points in the procedure, indicated in the procedure as PAUSE 6 
POINTS. 7 
Whole-organ or whole-body imaging. We use a commercially available LSFM 8 
(Ultramicroscope, LaVision BioTec) supplied with an optimized macrozoom microscope 9 
(MVX-ZB10, Olympus) and an sCMOS camera (Andor NEO 5.5, 2560 × 2160 pixels). A 10 
customized sample holder is also used for larger brain and body samples and soft 11 
abdominal organs (Fig. 4a). A suitable pair of excitation laser and emission filters is also 12 
installed. We typically use 100 mW of 488 nm laser-ET525/50 emission filter for green, 13 
and 50 mW of 588 nm laser-ET650/60 emission filter for red to far-red fluorescence. 14 
The size of the acquired image per pixel is dependent on the zoom of the microscope so 15 
that one pixel is approximately ~5.2 × 5.2 μm at 2× zoom and one pixel is ~6.5 × 6.5 μm 16 
at 1.6× zoom. These pixel sizes are sufficient for detecting signal from single cells in 17 
regions such as the cerebral cortex, or even from subcellular structures when they were 18 
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sparsely labeled, as discussed below (Fig. 4b-f, Supplementary Video 1). Users can 1 
also use higher magnified zoom values (~6.3×) if finer resolution is needed. Z-step size 2 
is selected according to the thickness of laser sheet. We typically select the thinnest 3 
sheet of the used LSFM and set 10 μm as the Z-step size. For further image analysis as 4 
below, both signal images (e.g. transgenes) and structural images via whole-organ 5 
counterstaining should be collected. To ensure sharpness of signals throughout the 3D 6 
image, data of the same sample from different directions (D-V and V-D in the case of 7 
whole-brain imaging) are also collected. This is recommended because the ventral 8 
horizontal slices are sharper in V-D images and dorsal horizontal slices are sharper in 9 
D-V images (Fig. 5)18. 10 
If a proper LSFM is not available, widely used confocal or two-photon 11 
microscopies can be also used. Partially cleared samples by one-step immersion in 12 
reagent-1 for 1-3 d are even applicable to deep region imaging with a two-photon 13 
microscopy18, because the clearing performance surpasses some of other clearing 14 
methods developed for these imaging purposes19. Microscopy venders have released 15 
objective lenses for deep tissue imaging (e.g. Olympus XLPLN10XSVMP, 10×/0.6, WD 16 
= 8 mm, ne = 1.33-1.52 and XLSLPLN25XGMP, 25×/1.0, WD = 8 mm, ne = 1.41-1.52; 17 
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Zeiss LD Plan-Aphochromat 20×1.0 WD = 5.6 mm, ne = 1.43-1.47; Leica HC FLUOTAR 1 
L25×/1.00, WD = 6 mm, ne = 1.457). 2 
All raw image data collected in an uncompressed TIFF format (16-bit images for 3 
the LSFM, Fig. 4b) are typically about ~7 GB in total per brain/color/direction and thus 4 
25-30 GB for a single brain dataset (structural/signal images and D-V/V-D directions). 5 
Therefore, a high-spec PC with a large memory size and good graphic board should be 6 
used for 3D reconstitution (Fig. 4c-h). We use a Windows PC with Intel(R) Core(TM) 7 
i7-3970X CPU @ 3.50GHz, 64 GB RAM and NVIDIA GeForce GTX 690 and Imaris 8 
software installed. 9 
CUBIC informatics. Here we show the step-by-step procedures for data processing 10 
(steps 7-15). For preprocessing of raw data, each TIFF stack (Fig. 5, “Collect raw 11 
images”) is first converted to a 3D image in the NIfTI-1 data format (.nii extension) 12 
introduced by the Neuroimaging Informatics Technology Initiative (NIfTI) 13 
(http://nifti.nimh.nih.gov/nifti-1/). NIfTI-1 files are visualized using software such as 14 
ITK-SNAP25. Due to the memory limitations of the current software tools, files need to 15 
be downscaled to 25% by discarding three of every four images of the TIFF Z-stack 16 
series and changing the resolution of these images from 2560 × 2160 to 640 × 540 (Fig. 17 
5, “Downscaling”). This limitation should be overcome with future development of image 18 
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informatics tools. The downscaling procedure is done using ImageMagick 1 
(http://imagemagick.org/) to create a temporary stack of 16-bit PNG files for each 2 
original TIFF stack. Then, each PNG stack is converted to a NIfTI-1 file using the 3 
Convert3D tool from ITK-SNAP (Fig. 5, “Convert to NIfTI-1”). In this step, specification 4 
of the correct spacing (given the pixel number of raw image data and downscaling 5 
parameters) and the orientation (which depends on the acquisition direction) is needed.  6 
In preparation for merging NIfTI-1 data in the same color channel of the same 7 
brain acquired from opposite directions (D-V and V-D), the files need to be aligned (Fig. 8 
5, ''Align D-V and V-D''). In this step, a pair of NIfTI-1 data images, the structural and 9 
signal images, is processed. The structural image is used to calculate the 10 
transformation parameter which is needed to align the D-V image to the V-D image. 11 
This is calculated by the ANTS function of the ANTS software. The transformation can 12 
allow deformation (e.g. Symmetric Normalization) or be restricted to affine operations 13 
only. Then, using the WarpImageMultiTransform function in ANTS, we apply the 14 
transformation parameters to align both structural and signal images of the D-V image 15 
to the V-D image. 16 
Next, we merge the aligned images in order to ensure sharpness throughout the 17 
resulting 3D image (Fig. 5, ''Combine D-V and V-D''). To do so, we use the Prewitt 18 
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operator27 to calculate the “edge content” of the two images (as a proxy for image 1 
sharpness). This is used to define two thresholds, n and m, so that slices below n only 2 
come from the V-D image, slices above m only come from the D-V image, and slices in 3 
between the two are a linear combination of the two images. We then take the image 4 
pairs and the thresholds, and create the merged NIfTI-1 image. In order to access the 5 
values of individual pixels in the images, we use the fsl2ascii and fslascii2img functions 6 
of FSL28. The steps above produce a pair of D-V + V-D composite NIfTI-1 data for both 7 
structural and signal images. 8 
Then, to facilitate analysis across different brain datasets, we align these merged 9 
NIfTI-1 files, which permits subtraction of signal images to be calculated. We show an 10 
example of Arc-dVenus Tg mouse brains with or without light stimuli18, which express a 11 
destabilized version of yellow fluorescence protein Venus under control of the Arc gene 12 
promoter26 (Fig. 6a). First, the raw data are preprocessed as in Fig. 5. Then, the 13 
composite NIfTI-1 images from different samples are aligned (Fig. 6b). As before, 14 
images are processed in pairs (structural and signal images), and the process relies on 15 
ANTS and WarpImageMultiTransform. We first align all brain datasets from the same 16 
experiment to an internal reference (i.e. one of the brain images among the samples of 17 
that experiment). Then, the internal reference is registered to a brain atlas such as the 18 
17 
 
Allen Brain Atlas29. These calculations thus provide the aligned 3D images to an atlas 1 
(Fig. 6c). Finally, the signal channel images of different brains are compared. To do so, 2 
we normalize these aligned images so that the median intensity inside the brain is the 3 
same across all brains. Then, the fslmaths function is used to compare pairs of brains by 4 
subtracting one image from the other (Fig. 6d). We provide the set of scripts for all steps 5 
and a brief user guide as Supplementary Data, with up-to-date versions also available 6 
on a GitHub repository (https://github.com/SystemsResearch/CUBIC_nprot). On our 7 
website (http://cubic.riken.jp), we also share example raw tiff data of Arc-dVenus Tg 8 
mice shown in Fig. 6 and NIfTI-1-converted Allen Brain Atlas data. 9 
Limitations of the current version of CUBIC. CUBIC was developed and optimized 10 
for whole-organ and whole-body imaging and informatics analysis developed to enable 11 
a comprehensive pipeline. Thus, there are several important advantages to CUBIC 12 
compared to other clearing methods. The first is the active tissue decoloring ability. This 13 
is mild to proteins, as opposed to the simple flushing or harsh decolorization methods 14 
with peroxidase or acetone used previously30, 31. This enables a wide range of 15 
applications for not only the brain but also other organs inside (Table 1). 16 
Because aqueous reagents are used to clear tissue, and fluorescent signals 17 
are preserved, tissues can be imaged by fluorescence microscopies. To achieve 18 
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efficient clearing for LSFM application, the optimal CUBIC reagent comprises five 1 
chemicals (Table 2) and takes days to two weeks to process. However, the procedure 2 
can be modified for the user's purpose: for example if users plan to image by 3 
two-photon microscopy, a one-step immersion in reagent-1 for 1-3 d is sufficient18.  4 
The actual scalability of CUBIC has not yet been fully investigated. So far, we 5 
tested a hemisphere of infant marmoset, and infant and adult whole mice18, 19 (Table 1). 6 
Clearing of these samples was efficient: for example, in the case of cleared infant 7 
mouse, internal structures of the brain could be imaged directly even through the skull19. 8 
However, we have not yet tested adult primate brains (e.g. marmoset), although we 9 
plan to investigate this in future studies. While clearing of larger adult primate brains 10 
might be more difficult, longer incubation times and CB-Perfusion may address this 11 
issue. The PACT/PARS protocol of CLARITY has apparently achieved a similar 12 
scalability and may be considered as an alternative. 13 
Whether a tissue clearing method can be combined with particular dyes or 14 
stains is an important consideration when selecting the clearing method. Whole-organ 15 
nuclei staining for anatomical annotation, registration and image analyses has been 16 
achieved using the CUBIC clearing procedure18, 19. Although we did not test other 17 
variations of dyes, possible limitations on some labeling methods, particularly lipophilic 18 
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dye labeling (e.g. Dil and related dyes), may exist given that the CUBIC clearing 1 
reagents massively remove lipids. Dyes or proteins should be fixed by PFA before 2 
clearing. In this sense, fluorescent proteins fused to a membrane protein can be 3 
observed in the cleared tissue while lipophilic dyes such as Dil may not be readily fixed 4 
by PFA due to their chemical structures and thus may be removed during clearing. This 5 
may be a drawback to CUBIC, in which case other clearing methods (e.g. ClearT11, 6 
SeeDB10, FRUIT14) should be considered. 7 
Structural distortion has been carefully addressed in some of clearing methods, 8 
such as SeeDB, and may need to be considered when clearing tissues with the other 9 
methods. Although we did not observe obvious changes in brain tissue even in the 10 
detailed subcellular structures including the axon and spine18, such structural distortion 11 
may happen given that CUBIC reagents remove a large proportion of the lipids and 12 
cause transient swelling during the procedure. In addition, CUBIC has not yet been 13 
optimized to fully clear bone and melanin pigments (Table 1). However, this issue 14 
remains unaddressed by other clearing methods also, so we are unable to suggest a 15 
suitable alternative in this scenario. Thus this issue needs further investigation in future 16 
studies.  17 
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 As discussed earlier, imaging resolution is a point to be considered as well. We 1 
have detected and counted signals from a single cell, and in this manuscript we 2 
therefore define this as providing 'single-cell resolution'. This criterion is roughly 3 
evaluated by using spot analysis of Imaris software in the dataset in Fig. 4 4 
(hippocampal cells of Thy1-YFP-H Tg) (Supplementary Video 1). In our opinion the 5 
criterion is overall supported by the calculated optical resolution. According to the 6 
vender's specifications, the optical resolution of microscopy that we use in this 7 
manuscript has 4.2 μm and 3.7 μm in X-Y images with 1.6× and 2× zoom, respectively. 8 
The thickness of light sheet is under 10 μm at the thinnest region, smaller than the 9 
typical step size (10 μm). In a typical nuclei-stained image, a 2.5 μm in half diameter 10 
sphere of a stained nuclei is detected as 2.5 + 3.7 μm in half diameter (actual half 11 
diameter + optical blurring of lens according to the definition of Rayleigh criterion) when 12 
2× zoom (5.2 μm × 5.2 μm per pixel) is used. To distinguish two neighboring cells, two 13 
parameters need to be considered: Exclusion volume (EV), the average voxel volume 14 
per cell calculated from cell density; and s, the voxel volume of nuclei acquired by 15 
camera (considered both cell/nuclei diameter and optical blurring). Each nucleus is 16 
detectable and separable if EV is sufficiently larger than s. By our calculations, s = 3 × 3 17 
× 2 voxels (= 15.6 × 15.6 × 20 μm = 4867.2 μm3, enough to include a sphere with 2.5 + 18 
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3.7 μm in its half diameter). EV of mouse cerebral cortex neuron is 11000 μm3/cell32 = 1 
(22.2 μm)3 = 5 × 5 × 3 voxels, which is sufficiently larger than the voxel volume used in 2 
this study, whereas EV of mouse hippocampal CA1 is 3900 μm3/cell33 = (15.7 μm)3 = 3 3 
× 3 × 2 to 4 × 4 × 2 voxels which is at the limit of resolution in the examples of current 4 
manuscript. Thus, the acquired image at its best has 'single-cell resolution' in the cortex 5 
and regions with similar cell density, while the voxel size is not sufficient for ‘single-cell 6 
resolution’ in denser regions such as the hippocampus or cerebellar granule layer. 7 
Further considerations are that the thinnest area of the sheet is limited and does not 8 
cover the entire imaged field. Also, the analysis software used in this manuscript does 9 
not support large image data and collected data must be downscaled. While CUBIC has 10 
the potential to detect all signals with single-cell resolution, these issues will need to be 11 
further addressed in future studies. 12 
  13 
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MATERIALS 1 
REAGENTS 2 
Animal samples used for imaging 3 
• Animals expressing fluorescent proteins can be used. Strong expression of a bright 4 
fluorescent protein gives the best imaging results. A bright red fluorescent protein 5 
such as mKate2 is best. So far, we have confirmed good imaging performance with 6 
Thy1-YFP-H Tg (The Jackson Laboratory), R26-H2B-EGFP KI (RIKEN CDB), 7 
R26-H2B-mCherry KI (RIKEN CDB), R26-CAG-nuc-3×mKate2 KI (RIKEN CDB & 8 
QBiC), β-actin-CAG-nuc-3×mKate2 KI (RIKEN CDB & QBiC), CAG-EGFP Tg (Japan 9 
SLC,Inc.), and Arc-dVenus Tg (Gifu University). We also usually use C57BL/6 (CLEA 10 
Japan, Inc.) to prepare cleared organs and bodies. ! CAUTION Animals experiments 11 
must be performed in accordance with governmental and institutional regulations 12 
regarding the use of animals for research purposes. All animal experiments and 13 
housing conditions in this manuscript were approved by the Animal Care and Use 14 
Committee of the RIKEN Kobe Institute, The University of Tokyo and the Gifu 15 
University, and all of the animals were cared for and treated humanely in accordance 16 
with the Institutional Guidelines for Experiments using animals.  17 
Fixative, perfusion and storage reagents 18 
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• PBS tablets (Takara, cat. no. T9181) 1 
• Heparin sodium (Mochida Pharmaceutical, 10000 U/10 mL) 2 
• PFA (Nacalai Tesque, cat. no. 02890-45) ! CAUTION PFA is toxic. Perform all 3 
procedures in a fume hood. 4 
• HCl (Nacalai Tesque, cat. no. 18320-15 or 18321-05) ! CAUTION HCl is toxic. 5 
Perform all procedures in a fume hood. 6 
• NaOH (Nacalai Tesque, cat. no. 31511-05) ! CAUTION NaOH is toxic. Perform all 7 
procedures in a fume hood. 8 
• Sucrose (Nacalai Tesque, cat. no. 30403-55 or 30404-45) 9 
• TISSUE TEK O.C.T. compound (Sakura Finetek, cat. no. 4583) 10 
• 1/2 diluted ScaleCUBIC-1 (1/2 reagent-1). ScaleCUBIC-1 is mixed with an equivalent 11 
volume of distilled water. ▲CRITICAL ScaleCUBIC-1 should not be diluted with PBS, 12 
because contamination of salt decreases the clearing performance. 13 
Clearing, nuclei-staining and imaging reagents 14 
• N,N,N’,N’-Tetrakis(2-hydroxypropyl)ethylenediamine (Quadrol, Tokyo Chemical 15 
Industry, cat. no. T0781) 16 
• 2,2',2"-Nitrilotriethanol (triethanolamine, Wako, cat. no. 145-05605) 17 
• Urea (Nacalai Tesque, cat. no. 35904-45 or 35907-15) 18 
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• Polyethylene glycol mono-p-isooctylphenyl ether (Triton X-100). ▲CRITICAL In our 1 
first CUBIC paper18, we mentioned that the quality of Triton X-100 product seems 2 
critical for preserving fluorescent signals and we recommended a product from 3 
Nacalai Tesque (cat. no. 25987-85). We further checked the same chemical from 4 
Sigma-Aldrich (cat. no. X100, T9284, T8787, T8532) or Tokyo Chemical Industry (cat. 5 
no. P0873), and neither of them caused fluorescent quenching in the final reagent-1 6 
recipe in a short term and thus can be used as substitutes. 7 
• Sucrose (Nacalai Tesque, cat. no. 30403-55 or 30404-45) 8 
• Sodium azide (Nacalai Tesque, cat. no. 31208-82) ! CAUTION Sodium azide is 9 
highly toxic. 10 
• SYTO 16 (Life Technologies, cat. no. S7578) 11 
• Propidium iodide (PI, Life Techologies, cat. no. P21493) 12 
• Silicon oil TSF4300 (Momentive, RI = 1.498) 13 
• Mineral oil (Sigma-Aldrich, RI = 1.467, cat. no. M8410) 14 
EQUIPMENT 15 
• 5-ml tube (Eppendorf, cat. no. 0030119.401SG) 16 
• 15-ml conical tube (Corning, cat. no. 352096 or 188271) 17 
• 30-ml conical tube (Sarstedt, cat. no. 60.544) 18 
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• 50-ml conical tube (Corning, cat. no. 352070 or 227261) 1 
• Peristaltic pump (EYELA, model: MP-2000) (Fig. 3a) 2 
• 23G intravenous injection needle, butterfly type (Terumo, cat. no. SV-23CLK) 3 
• 26G×1/2” injection needle (Terumo, cat. no. NN-2613S) 4 
• T shape stopcock (Terumo, cat. no. TS-TL2K) 5 
• 1 ml, 10 ml and 20 ml disposable syringe (Terumo, cat. no. SS-01T, SS-1010SZ, 6 
SS-20ESZ) 7 
• Vacuum desiccator (AS ONE, cat. no. VXS 1-5943-01) with vacuum pump (ULVAC, 8 
model: DA-15D) (Fig. 2b) 9 
• Incubation devices. We use hybridization incubator (TAITEC, model: HB-80, Fig. 2c) 10 
or incubator (EYELA, model: FMS-1000 or MHS-2000) with rotator (TAITEC, model: 11 
RT-5) 12 
• Shaker (TAITEC, model: Wave-PR or MixerXR-36, Fig. 2d) 13 
• Magnetic stirrer for preparing highly viscous reagent (ASH, model: AMG-S, or IKEDA 14 
Scientific, model: IS-20PC) 15 
• Hot stirrer for preparing highly viscous reagent (IKA, model: C-MAG HS10, or 16 
Advantec, model: SRS710HA) 17 
• pH meter (HORIBA scientific, model: LAQUA twin) 18 
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• Positive displacement pipettor (Gilson, model: Microman M-1000). ▲CRITICAL We 1 
highly recommend this pipettor to measure the weight of the viscous materials such 2 
as Triton X-100 and aminoalcohols. 3 
• Microwave 4 
• Fume hood 5 
Imaging microscopy for whole mouse organs 6 
• Light-sheet illumination device with a macrozoom microscope4, 18 7 
In this study, we used Ultramicroscope from LaVision BioTec and MVX-ZB10 from  8 
Olympus, equipped with 9 
• Olympus MVPLAPO0.63X lens (NA = 0.15, working distance = 87 mm) 10 
• Imaging reservoir (100% quartz) (LaVision BioTec) 11 
• Sample holder (LaVision BioTec or customized) (Fig. 4a) 12 
• Green fluorescent signal filter (Chroma ET525/50) 13 
• Red fluorescent signal filter (Chroma ET650/60) 14 
• Coherent sapphire laser 488LP-100 15 
• Coherent sapphire laser 588LP-50 16 
• Andor sCMOS CCD camera Neo 5.5. The camera and the MVX microscope are 17 
connected to a camera adaptor (Olympus MVX-TV1X), tube lens (Olympus 18 
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MVX-TLU), and the Ultramicroscope filter wheel unit (LaVision BioTec) with adaptors 1 
(LaVision BioTec, LV AD MVX-1 and LV AD MVX-2)18 (Fig. 4a). 2 
• Customized sample holder 3 
• Glass plate for specimen mounting stage 4 
Image analyzing software 5 
General image analysis tool 6 
• ImageJ (freeware from the US National Institutes of Health (NIH)) 7 
Visualization tool 8 
• Imaris (Bitplane, http://www.bitplane.com/imaris/imaris) for 3D reconstitution of TIFF 9 
image stacks 10 
• ITK-SNAP (freeware from Paul Yushkevich, Ph.D. at the University of Pennsylvania 11 
and Guido Gerig, Ph.D. at the University of Utah, DL URL: 12 
http://www.itksnap.org/pmwiki/pmwiki.php) for NlfTl-1 3D images 13 
Analysis tool 14 
• Python and a C++ compiler 15 
• Code provided as Supplementary Data 16 
• ImageMagick (http://imagemagick.org/) installed with TIFF support 17 
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• Convert3D 1 
(http://www.itksnap.org/download/snap/process.php?link=7074&root=nitrc) 2 
• ANTs 1.9-v4 (ANTs, freeware from stnava, DL URL: 3 
http://sourceforge.net/projects/advants/files/ANTS/ANTS_Latest/) 4 
• FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FslInstallation) 5 
REAGENT SETUP 6 
Phosphate buffered saline (PBS) Prepare according to vendor’s manual. When using 7 
PBS tablets (Takara, cat. no. T9181), the tablet is dissolved in 1 liter of distilled water. 8 
When PBS/0.01% (wt/vol) sodium azide is prepared, directly dissolve 0.1 g of sodium 9 
azide in the 1 liter of PBS. This solution can be stored at room temperature (18–25 °C) 10 
for several months. 11 
Paraformaldehyde (PFA) solution To prepare 4% (wt/vol) PFA in PBS, dissolve 40 g 12 
of PFA in 1 liter (total) of PBS. Heat the PBS solution (avoid boiling) and add PFA 13 
powder and 1/500-1/1000 volume of 1 N NaOH to help dissolving PFA faster. After 14 
complete dissolution, adjust the pH to 7.4 using HCl. PFA can be stored at -20°C until 15 
use for several months. ▲CRITICAL The pH value of PFA is a critical factor for an 16 
efficient clearing with lower autofluorescence. ! CAUTION PFA is a very toxic reagent. 17 
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Avoid inhalation or contact with skin and eyes. Use a draft chamber, proper gloves and 1 
a mask to handle PFA, HCl, and NaOH. 2 
80 wt% Quadrol Quadrol is a highly viscous liquid and can be used as an 80 wt% 3 
working solution. In this case, add 125 g of distilled water to a 500 g of Quadrol reagent 4 
bottle and stir for at least 30 min. Store the solution at room temperature for up to one 5 
month. ▲CRITICAL Quadrol is highly viscous and we use wt% rather than % (wt/vol) 6 
or % (vol/vol) for convenience. 7 
ScaleCUBIC-1 (Reagent-1) Reagent-1 is a mixture of urea (25 wt% final concentration), 8 
Quadrol (25 wt% final concentration), Triton X-100 (15 wt% final concentration) and 9 
distilled water. For example to prepare 500 g of reagent-1 solution, mix 125 g of urea, 10 
156 g of 80 wt% Quadrol in 144 g of distilled water until complete dissolution at room 11 
temperature (or with heating if needed) and further add 75 g of Triton X-100. Finally, 12 
degas the reagent with a vacuum desiccator (~0.1 MPa, ~30 min) (Fig. 2b). The 13 
reagent can be stored at room temperature for up to one month. Prepare 1/2 reagent-1 14 
by mixing 1:1 of reagent-1 and distilled water. ▲CRITICAL Quadrol and Triton X-100 15 
are viscous and therefore we use wt% rather than % (wt/vol) or % (vol/vol) for 16 
convenience. Reagent-1 should not be prepared with PBS, because contamination of 17 
salt decreases the clearing performance. We usually use the stocked solution but longer 18 
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storage may cause quenching of fluorescent signals. Avoid excess heating during 1 
preparation 2 
? TROUBLESHOOTING  3 
ScaleCUBIC-2 (Reagent-2) Reagent-2 is a mixture of urea (25 wt% final concentration), 4 
sucrose (50 wt% final concentration), triethanolamine (10 wt% final concentration) and 5 
distilled water. To prepare 50 g of reagent-2 solution, dissolve 12.5 g of urea and 25 g of 6 
sucrose in 7.5 g of distilled water with microwave and hot stirrer (Fig. 2a). After 7 
complete dissolution (typically it takes 10-15 min), cool the mixture at room temperature, 8 
add 5 g of triethanolamine, and stir further. The 0.1% (vol/vol) of Triton X-100 included 9 
in the original recipe18 is not necessary. Finally, degas the reagent with a vacuum 10 
desiccator (~0.1 MPa, ~30 min) (Fig. 2b). Prepare 1/2 reagent-2 by mixing 1:1 of 11 
reagent-2 and PBS. Reagent-2 can be stored at room temperature for up to two weeks. 12 
▲CRITICAL Reagent-2 becomes highly viscous and therefore we use wt% rather 13 
than % (wt/vol) or % (vol/vol) for convenience. Because water evaporation will make it 14 
difficult for highly concentrated chemicals to dissolve, the weight should be monitored 15 
for the addition of evaporated water after completely dissolving urea and sucrose. Avoid 16 
boiling during the preparation. ▲CRITICAL Reagent-2 should not be prepared with 17 
PBS, because contamination of salt decreases the clearing performance. We use PBS 18 
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only in preparing 1/2 reagent-2/PBS, because tissues after reagent-1 treatment tend to 1 
be easily swollen in 1/2 reagent-2/water, which might cause distortion of overall 2 
structure, and because the gradual exchange from PBS through 1/2 reagent-2/PBS to 3 
salt-free reagent-2 does not affect the final transparency. Before clearing, 1/2 4 
reagent-1/water is not a problem. ▲CRITICAL Make sure that there is no precipitation 5 
in the reagent-2 solution stock before use. The precipitation in the stock can be 6 
dissolved again by mild heating with microwave. Insufficient degassing may cause 7 
bubbles around and inside the tissue during reagent-2 treatment. ! CAUTION The acrid 8 
ammonia smell in these reagents indicates degradation of urea. Generation of ammonia 9 
itself is not apparently a problem because the reagents are buffered with aminoalcohol 10 
in alkaline pH range (~pH 11)19. We recommend users to avoid excess heating during 11 
preparation. If users experience the smell during clearing, change to the fresh media. 12 
? TROUBLESHOOTING 13 
Immersion oil mix Mix 1:1 of TSF4300 and mineral oil completely with stirrer and 14 
degas with a vacuum desiccator (~0.1 MPa, ~30 min) (Fig. 2b) before use. The oil mix 15 
can be repeatedly used for imaging by filtering contaminants (clearing reagents etc.). Its 16 
RI is 1.48-1.49, a comparable RI of reagent-2. The oil can be wiped out with 70% EtOH. 17 
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▲CRITICAL The mix ratio can be optionally changed because the best RI matching 1 
may be different between organs. 2 
EQUIPMENT SETUP 3 
Surgical setup for CB-Perfusion protocol Typical surgical setup for CB-Perfusion is 4 
depicted in Fig 3a. In the protocol, the adult mouse is perfused with four solutions:(1) 5 
20-30 ml of cold heparin-PBS, (2) 150 ml of cold 4% (wt/vol) PFA, (3) 20 ml of PBS, (4) 6 
20-30 ml of 1/2 diluted reagent-1. We recommend that PFA is perfused by peristaltic 7 
pump for successful and reproducible surgeries. Thus, we devised a surgical instrument 8 
with a combination of T shape stopcocks, a peristaltic pump connected with silicon tube, 9 
an intravenous injection needle, and a disposable syringe as shown in Fig 3a. ! 10 
CAUTION PFA is a very toxic reagent. Avoid inhalation or contact with skin and eyes. 11 
Use a draft chamber, proper gloves and a mask to handle PFA. Great care in handling 12 
the injection needle is needed to avoid accidental needlesticks. 13 
  14 
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PROCEDURE 1 
Anesthesia ● TIMING 5 min 2 
1| At day 0, deeply anesthetize the mice using pentobarbital (~150 mg/kg of body 3 
weight, administer intraperitoneally with 1 ml syringe and 26G×1/2” injection needle). 4 
! CAUTION Every experiment must follow all government and institutional guidelines for 5 
the use of experimental animals. 6 
 7 
Transcardial perfusion and tissue clearing ● TIMING 4-14 d 8 
▲CRITICAL In this step, we particularly focus on the full clearing protocol for the 9 
purpose of LSFM imaging. However, the immersion period and the final transparency of 10 
samples can be varied according to user’s experimental purpose.  11 
2| Start clearing organs by simple immersion protocol (option A) or CB-Perfusion and 12 
immersion protocol (option B) (CB-Perfusion clears better than the immersion protocol, 13 
particularly in heme-rich organs, but tends to cause decreased signal intensity due to 14 
the shorter fixation time). Alternatively start clearing a whole-body by the CB-Perfusion 15 
protocol (option C). 16 
▲CRITICAL STEP Option A is for a single whole mouse brain (Fig. 2) and may need 17 
some modifications when other organs are cleared. Because handling of whole-body 18 
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samples in the viscous reagent-2 become difficult, particularly due to causing bubbles, 1 
the cleared whole body with option C is kept in reagent-1 but not in reagent-2. 2 
(A) Simple immersion protocol for dissected whole brain  3 
(i) Day 0: Perfuse the mice with 10 ml of cold PBS (pH 7.4) containing 10 U/ml of 4 
heparin at ~10 ml/min to remove the blood from the organ as much as possible. 5 
Then, perfuse ~25 ml of cold 4% (wt/vol) PFA (pH 7.4) at ~10 ml/min. Dissect the 6 
brain and postfix in 10 ml of 4% (wt/vol) PFA with shaking at 4°C for 18-24 h. 7 
▲CRITICAL STEP Cooling of PBS and 4% (wt/vol) PFA on ice is important for 8 
successful perfusion. Muscle stiffness after perfusion is a good indicator of 9 
successful perfusion. Residual blood in the mouse brain increases 10 
autofluorescence especially in the green-laser excitation. The pH value of PFA is 11 
also critical for efficient clearing and lower autofluorescence. Overfixation causes 12 
both lower clearing efficiency and autofluorescence. 13 
? TROUBLESHOOTING  14 
(ii) Day 1: wash the tissue sample with 10 ml of PBS/0.01% (wt/vol) sodium azide for 15 
at least 2 h twice at room temperature to remove the remaining PFA. (Fig. 2e, 16 
“Fixed brain” panel) 17 
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■ PAUSE POINT The fixed organs can be stored. First immerse them in 10 ml of 1 
20-30% (wt/vol) sucrose in PBS per organ with shaking at 4°C for 1-2 d. When 2 
samples sink to the bottom, put them into O.C.T. compound and immediately 3 
transfer to –80°C. To continue the clearing protocol, thaw samples gradually at 4 
room temperature, wash with PBS at least twice, with each wash for 1 h, to remove 5 
sucrose and O.C.T. compound. The sample will now be ready for the next step, 6 
however, we find the clearing efficiency is reduced in samples that have been 7 
stored. 8 
(iii) Immerse the sample in 8-10 ml of 1/2 water-diluted reagent-1 with shaking (~60 9 
r.p.m. if using the orbital shaker of a hybridization oven in Fig. 2c, ~30 r.p.m. if 10 
using a seesaw shaker in Fig. 2d) or rotation (~5 r.p.m.) at 37°C for 3-6 h. We 11 
recommend using a 30-ml of conical tube for clearing a single brain rather than a 12 
15-ml tube in this and further clearing steps (iv-v) because of sample swelling. 13 
Clearing effects can be observed during this step (Fig. 2e, “1/2 reagent-1” panel). 14 
Note that a nuclear staining dye, such as SYTO 16 (1-2 µM) and PI (5-10 µg/ml), 15 
can also be added to 1/2 diluted reagent-1 at this step. 16 
▲CRITICAL STEP Inefficient mixing of the reagent and samples during clearing 17 
may affect the final clearing performance. Pretreatment with 1/2 diluted reagent-1 18 
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gives a more effective final clearing efficiency than direct immersion in reagent-1. 1 
However, this step can be skipped for other purposes such as two-photon imaging 2 
with a partially cleared sample, for example18. This direct immersion procedure 3 
gives better clearing results than some other clearing methods19 and can be used 4 
for two-photon imaging18 and possibly as part of the sample preparation for 5 
single-photon imaging. 6 
(iv) Discard 1/2 diluted reagent-1. Immediately add 8-10 ml of reagent-1 and gently 7 
shake or rotate the sample at 37°C overnight. If desired, the same concentration of 8 
nuclear staining dye used in the previous step should be added to reagent-1. 9 
! CAUTION Reagent-1 can erase oily pen marks easily. Make sure the tube is 10 
sealed by wrapping parafilm around the lid/top of it. Sample labels should be 11 
written on both the body and lid of the tube to avoid loss of information. An 12 
ammonia smell indicates degradation of urea, and that the reagent should be 13 
replaced by fresh media. 14 
? TROUBLESHOOTING 15 
(v) Day 2: replace 8-10 ml of reagent-1 and continue gentle shaking or rotating at 37°C. 16 
Replace the reagent every two days (day 4 and 6). Also refresh any nuclear 17 
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staining dye on day 4 and day 6. Typically, the brain will be sufficiently cleared by 1 
day 7-8 (Fig. 2e, “Reagent-1” panel). 2 
▲CRITICAL STEP If the white matter has not significantly cleared by 8-day 3 
immersion, try further immersion by placing into fresh reagent-1 for an additional 4 
1-2 d. 5 
! CAUTION Since CUBIC-treated organs soften, we recommend using spoons 6 
instead of forceps for handling them in order to avoid damage. 7 
? TROUBLESHOOTING 8 
(vi) Day 7-10: To stop the clearing procedure, wash the sample with 20 ml of 9 
PBS/0.01% (wt/vol) sodium azide with gentle shaking or rotating at room 10 
temperature for at least 2 h × 3 times. We typically wash the sample for 2 h × 1, 11 
overnight × 1 and 2 h × 1. When a sample is stained with PI, further staining during 12 
this step is needed: thus incubate the washed sample in ~5 ml of PBS/0.01% 13 
(wt/vol) sodium azide containing 5-10 µg/ml of PI for additional 3 d (or more, if 14 
needed) at 37°C with rotation18. 15 
▲CRITICAL STEP Complete removal of reagent-1 during the washing step is 16 
critical for final clearing efficiency. 17 
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■ PAUSE POINT Organs can be stored. First immerse them in 10 ml of 30% 1 
(wt/vol) sucrose in PBS/0.01% (wt/vol) sodium azide per organ with shaking at 2 
room temperature overnight. When samples sink to the bottom, put them into 3 
O.C.T. compound and immediately store them at –80°C. Thaw as described in the 4 
PAUSE POINT at step (ii). 5 
! CRITICAL STEP For cryoprotection at this step, we recommend using 30% 6 
(wt/vol) sucrose in PBS rather than 20% (wt/vol) sucrose solution to avoid any 7 
damage to the sample. 8 
? TROUBLESHOOTING 9 
(vii) Day 8-11: Degas the sample in a limited volume of PBS with a vacuum desiccator 10 
(Fig. 2b). To do this, immerse the sample in ~5 ml of 1/2 PBS-diluted reagent-2 11 
and shake it in 5 ml tube for 6 h to 24 h at 37°C or room temperature (Fig. 2e, “1/2 12 
reagent-2” panel). Check whether the sample sinks to the bottom (a sign of 13 
complete immersion). 14 
▲CRITICAL STEP Degassing of sample prevents air bubbles from remaining in 15 
the ventricle. 16 
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(viii) Day 8-11: Immerse the sample in ~5 ml of reagent-2 in a 5 ml tube and gently 1 
shake at 37°C overnight. The next day, replace the reagent with fresh reagent and 2 
further incubate for ~24 h (Fig. 2e, “Reagent-2” panel). 3 
! CAUTION Do not rotate the tube to avoid making bubbles. Samples do not sink in 4 
the highly viscous reagent-2 and it is difficult to take images in the reagent. The 5 
reagent-2-treated samples should be immersed in the low-viscous immersion oil 6 
mix at imaging steps. When structural distortion is apparent after reagent-2 7 
treatment at 37°C, try incubation at room temperature for a longer time. Adjustment 8 
of PBS content in 1/2 reagent-2 may also have an effect to mitigate unsuited 9 
shrinkage or swelling. 10 
■ PAUSE POINT Organs can be left in reagent-2 for up to one week at room 11 
temperature. Further immersion increases the final transparency but also causes 12 
swelling of the sample. After imaging, the sample can be washed with PBS/0.01% 13 
(wt/vol) sodium azide, completely immersed in 30% (wt/vol) sucrose in PBS/0.01% 14 
(wt/vol) sodium azide, and stored in O.C.T. compound at –80°C as described in the 15 
PAUSEPOINT to step (vi). 16 
? TROUBLESHOOTING 17 
(B) CB-Perfusion and immersion protocol for faster clearing of whole organs 18 
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(i) Prepare the surgical setup as shown in Fig. 3a. 1 
(ii) Day 0: Perfuse the mice with 20-30 ml of cold PBS (pH 7.4) containing 10 U/ml of 2 
heparin at ~10 ml/min to remove the blood from the tissues as much as possible. 3 
▲CRITICAL STEP Insufficient removal of blood inside the tissue prolongs the 4 
clearing period and may cause low clearing performance. 5 
(iii) Perfuse the mice with 150 ml of cold 4% (wt/vol) PFA in PBS (pH 7.4) at ~15 ml/min 6 
using a peristaltic pump. 7 
! CAUTION PFA is a very toxic reagent. Perform all procedures in a fume hood 8 
with a safety glass to avoid inhalation or contact with skin and eyes. 9 
▲CRITICAL STEP If the signal from a target reporter protein is weak, a prolonged 10 
perfusion period may be more effective, or clearing as described in option A.  11 
▲CRITICAL STEP Cooling of PBS and 4% (wt/vol) PFA on ice is important for 12 
successful perfusion. 13 
? TROUBLESHOOTING 14 
(iv) Perfuse the mice with 20 ml of PBS (pH 7.4) at ~10 ml/min to wash out PFA, 15 
followed by perfusion of 20-30 ml of 1/2 diluted reagent-1 at the same injection rate. 16 
Make sure that organs become translucent by the end of the perfusion (Fig. 3b). 17 
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Note that a nuclear staining dye, such as SYTO 16 (1-2 µM) and PI (5-10 µg/ml), 1 
can also be added to 1/2 diluted reagent-1 at this CB-Perfusion step. 2 
▲CRITICAL STEP Perfusion efficiency is crucial to the final clearing efficiency. 3 
Some organs such as the pancreas and spleen are good indicators to evaluate 4 
perfusion efficiency (Fig. 3b). 5 
(v) Dissect the organs of interest and immerse these in reagent-1. Several organs can 6 
be processed in a single tube, but the stomach and intestine should be separated 7 
into different tubes. Gastrointestinal content in these organs should be removed as 8 
much as possible in this step. Thus immerse several organs such as heart, lung, 9 
kidney, spleen, pancreas and a piece of liver in 40 ml of reagent-1 or immerse each 10 
small organ such as heart, lung, kidney, spleen, and pancreas in 5 ml of reagent-1. 11 
Incubate the samples with shaking (~60 r.p.m. if using an orbital shaker in a 12 
hybridization oven in Fig. 2c, ~30 r.p.m. if using a seesaw shaker in Fig. 2d) or 13 
rotation (~5 r.p.m.) at 37°C overnight. Add the same concentration of any nuclear 14 
staining dye used at step (iv) to reagent-1. 15 
▲CRITICAL STEP Efficient mixing of the reagent and samples during clearing 16 
may affect the final clearing performance. For efficient clearing, the samples of 17 
interest should be immersed in at least 5-fold volume of reagent-1. 18 
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! CAUTION Reagent-1 erases oily pen marks easily. Make sure the tube is sealed 1 
by wrapping parafilm around the lid/top of it. Sample labels should be written on 2 
both body and lid of the tube to avoid loss of information. An ammonia smell 3 
indicates degradation of urea, and in this scenario the reagent should be replaced 4 
with fresh media. 5 
? TROUBLESHOOTING 6 
(vi) Day 1: make sure that organs are transparent and the color of the supernatant has 7 
turned olive green. Replace reagent-1 with the same volume of reagent-1 and 8 
continue clearing shaking at 37°C. If appropriate, also refresh the nuclear staining 9 
dye. Replace reagent-1 and any nuclear staining dye again at day 2 and 4. The 10 
total incubation time for the complete clearing depends on the organ: 1-day of 11 
reagent-1 treatment is usually sufficient in the case of pancreas, spleen, and 12 
intestine. However, note that we treated all indicated organs in Fig. 3c with 13 
reagent-1 for 5 d. 14 
▲CRITICAL STEP Typically, successfully CB-Perfused-organs are turned almost 15 
transparent with the exception of liver and lung by day 1 (Fig. 3c). Opacity in the 16 
lung occurs mainly from bubbles. Note that the color change of the supernatant 17 
indicates decolorization of tissues due to heme elution. 18 
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? TROUBLESHOOTING 1 
(vii) Day 2-6: To stop the clearing procedure, wash the samples with same volume of 2 
PBS with gently shaking or rotating at room temperature for 2 h × 3 times. After the 3 
PBS wash, move to the next step immediately. 4 
! CRITICAL STEP CB-Perfused samples are prone to overshrink in the washing 5 
step. Do not wash the samples in PBS more than 3 times × 2 h. 6 
(viii) Immerse the sample in the same volume of 1/2 PBS-diluted glycerol and shake for 7 
6 h to 24 h at room temperature. Check whether the sample sinks to the bottom (a 8 
sign of complete immersion). 9 
(ix) Day 3-7: Immerse the samples in the same volume of reagent-2 and gently shake 10 
at 37°C overnight. The next day, replace the reagent with fresh reagent and further 11 
incubate for several days. Typically, an apparent transparency plateau is reached 12 
after 2-3 d of reagent-2 treatment. At day 10, almost all organs should be 13 
transparent as shown in Fig. 3c. The gastrointestinal content in stomach and 14 
intestine should be removed as much as possible before the following imaging 15 
step. 16 
! CAUTION To avoid making bubbles, do not rotate the tube. Samples do not sink 17 
in the highly viscous reagent-2 and it is difficult to take images in the reagent. The 18 
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reagent-2-treated samples should be immersed in the low-viscous immersion oil 1 
mix at imaging steps. When structural distortion is apparent after reagent-2 2 
treatment at 37°C, try the incubation at room temperature for a longer time. Or, test 3 
the simple immersion protocol (step (A)). 4 
? TROUBLESHOOTING 5 
■ PAUSE POINT Tissues can be left in reagent-2 for up to one week at room 6 
temperature. Further immersion increases the final transparency but also causes 7 
swelling of the sample. After imaging, the sample can be washed with PBS, 8 
completely immersed in 30% (wt/vol) sucrose in PBS, and stored in O.C.T. 9 
compound at –80°C, as in the PAUSE POINT for step (A) (vi) 10 
(C) CB-Perfusion protocol for whole-body clearing 11 
▲CRITICAL Here, we describe clearing of whole adult mouse body only using 12 
reagent-1. This overcomes the difficulties of handling whole-body samples in the 13 
viscous reagent-2, particularly due to bubble formation. For infant mouse whole-body 14 
imaging, perfusion and immersion of reagent-1 was sufficient (Table 1)19. Adult 15 
whole-body imaging is not applicable with the microscope setup introduced in this 16 
manuscript due to stage size limitations. 17 
(i) (Perform CB-Perfusion as described in option B) steps (i)-(iv). 18 
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(ii) Detach the skin from the body. Carefully remove as much pelage as possible. Make 1 
sure that the body is partially transparent following the CB-Perfusion. Typically, 2 
glands such as pancreas and submaxillary gland are almost transparent (Fig. 3d). 3 
Spleen is also as a good indicator of successful perfusion. Immerse the body in 200 4 
ml of reagent-1. Place the container on orbital shaker set at ~60 r.p.m. or seesaw 5 
shaker set at ~30 r.p.m. in the incubator at 37°C overnight. Use the same 6 
concentration of the nuclear staining dye used at step B (iv) and add to reagent-1 if 7 
desired. 8 
▲CRITICAL STEP Inefficient mixing of the reagent and samples during clearing 9 
may affect the final clearing performance. 10 
(iii) Replace the same volume of reagent-1 and continue gentle shaking at 37°C. 11 
Refresh the nuclear staining dye if used also. Replace the reagent (and any nuclear 12 
staining due) every day in the initial week, and every two or three days in the 13 
second week. Continue the clearing with reagent-1 for at least two weeks. Typically, 14 
major abdominal organs except bones and intestinal content become sufficiently 15 
transparent after two weeks of reagent-1 treatment (Fig. 3d).  16 
▲CRITICAL STEP An ammonia smell indicates degradation of urea, and the 17 
reagent should be replaced with fresh media in this case. 18 
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■ PAUSE POINT The whole body can be kept in reagent-1 for up to several 1 
months at room temperature. 2 
? TROUBLESHOOTING 3 
 4 
Imaging of the cleared tissues with the macrozoom LSFM ●  TIMING 1-3 5 
h/sample, timing is dependent on the number of samples, color and direction as well as 6 
required exposure time. 7 
▲CRITICAL To perform a rapid image acquisition of whole organs, a light-sheet 8 
illumination unit combined with a macrozoom microscope is suitable. Here we describe 9 
our setup using Ultramicroscope/MVX-ZB10 (LaVision BioTec/Olympus). A confocal or 10 
a multi-photon microscopy can be also applied but for more limited regions.  11 
3| Before imaging, wipe reagent-2-treated samples with a kimwipe softly to remove 12 
excess reagent-2 on the surface and then immerse the sample into the oil mix for 10 13 
min to 1 h. This process also helps remove bubbles around the tissue. If bubbles attach 14 
on the surface of the sample, carefully remove them with a needle or a tapered forceps. 15 
 16 
4| Set the imaging reservoir filled with the immersion oil mix, and then set the sample 17 
holder. Put a glass slide on the sample holder (Fig. 4a). 18 
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 1 
5| Put the sample on the glass slide (Fig. 4a). Acquire a live image with an appropriate 2 
laser/filter pair to adjust focus and the sample position to the center. A whole mouse 3 
brain image can be captured using 1.6× to 2× zoom of the MVX-ZB10.  4 
▲CRITICAL STEP To avoid fluorescent quenching, laser power should be weakened 5 
during the adjustment of position and focus. 6 
 7 
6| Set the focus position of illumination sheet, Z-range (in the case of whole brain, 8 
typically ~7 mm in total), Z-step size (typically 10 μm per step), laser power (typically 9 
70-100%) and exposure time (typically 50 ms to 1 s for each side). Each plane should 10 
be illuminated from both the right and left sides, and a merged image with max intensity 11 
saved. The exposure times should be adjusted according to the fluorescent signal 12 
intensities of each sample. After all parameters are adjusted, start image acquisition. 13 
When multi-color images are needed, repeat the image acquisition procedure with the 14 
same Z-range and re-adjusted laser power and exposure time. For collecting both D-V 15 
and V-D datasets, manually flip the sample upside down and acquire image again for 16 
this opposite orientation. 17 
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▲CRITICAL STEP To take images with a high signal-to-noise ratio, it is important to 1 
use bright fluorescent proteins and chemicals. Because ~700 images (~11 MB per 2 
image, total ~7 GB) are acquired per color/direction, each image should be saved to a 3 
secondary storage (e.g. a hard-disc drive) during acquisition. Each stack (one color, one 4 
direction) is saved to a different folder. For further signal comparison steps (step 7-15), 5 
signal and structural images of both D-V and V-D directions are needed. We 6 
recommend a simple naming rule for these folders with four fields separated by an 7 
underscore: information about the experiment (including imaging date), a unique ID for 8 
this brain, information about the imaging direction (“VD” or “DV”) and information about 9 
the channel (“nuclear” for the nuclear counterstaining and “geneExp” for the signal 10 
channel). For instance, 20131118LAdV_001_nuclear_DV. The code provided for the 11 
informatics section assumes that the naming convention is respected. It is also 12 
important to note that white spaces and special characters must be avoided.  13 
? TROUBLESHOOTING 14 
 15 
Informatics for signal comparison ● TIMING 8-9 h (for a 2-brain dataset, reduced 16 
to 1-2h if using affine registration instead of Symmetric Normalization) 17 
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▲CRITICAL We provide our source code and an additional user manual as 1 
Supplementary Data, as well as NIfTI-1-converted Allen Brain Atlas data and 2 
Arc-dVenus Tg mouse brain images used in Fig. 6 on our website (http://cubic.riken.jp). 3 
Note that timing is roughly proportional to the number of brains and vary on different 4 
computer specifications. 5 
 6 
7| If this is the first time the pipeline is being run, install all required software and copy 7 
the provided code to the computer used for the analysis. Compile the C++ files for edge 8 
detection (g++ -O3 edge_detection_Prewitt.cpp -o edge_detection_Prewitt) and file 9 
merging (g++ -O3 file_merging.cpp -o file_merging). 10 
 11 
8| Construct a 3D NIfTI-1 file for each TIFF stack with the convertTiffFiles.py script. This 12 
takes approximately 2 min per stack, and each brain sample corresponds to four stacks 13 
(two channels, two acquisition directions).  14 
? TROUBLESHOOTING 15 
 16 
9| Align images of the same brain acquired from opposite directions, with the 17 
sameBrainAlignment.py script. For each brain, this includes: registration of the 18 
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V-D-acquired nuclear counterstaining image to the D-V-acquired one, alignment of the 1 
V-D-acquired nuclear counterstaining image, alignment of the V-D-acquired signal 2 
channel image. The registration takes approximately 1 h 30 min using Symmetric 3 
Normalization or 3-5 min using affine transformations only, and both alignments take 4 
under a minute. 5 
? TROUBLESHOOTING 6 
 7 
10| Merge the V-D-acquired and D-V-acquired images. Use edgeDetection.py to 8 
calculate the n and m thresholds for each brain and channel (4 min per brain), and use 9 
these results in fileMerging.py to merge the files (7-8 min per brain). 10 
? TROUBLESHOOTING 11 
 12 
11| Choose one brain to be used as internal reference, and align all the other brains to 13 
this reference with internalAlignment.py (for each brain, approximately 1 h 30 min for 14 
the registration if using Symmetric Normalization or 3-5 min if using affine 15 
transformation only, and under a minute for the alignment of both channels). 16 
? TROUBLESHOOTING 17 
 18 
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12| Using atlasAlignment.py, register the internal reference to the brain atlas 1 
(approximately 1 h 30 min) and align all brains to the atlas (approximately 1 min per 2 
brain). 3 
? TROUBLESHOOTING 4 
 5 
13| Calculate the normalization factors (7 min, plus 7 min per brain) with 6 
median_brainOnly.py. 7 
? TROUBLESHOOTING 8 
 9 
14| Normalize and compare brains (e.g. for subtraction) with 10 
normalisation_comparison.py (exact timing dependent on comparison, but typically 11 
10-60 min). 12 
? TROUBLESHOOTING 13 
 14 
15| Export TIFF stack for the resulting files with exportTiffStack.py (about four min per 15 
NIfTI-1 file). 16 
▲CRITICAL STEP Although registration with SyN transformation is effective, in some 17 
cases it may cause structural deformation or distortion. Users can choose whether to 18 
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use SyN or affine-only registration. We recommend checking the quality of final aligned 1 
data and, if necessary trying SyN or affine-only instead. In this manuscript, we show 2 
data aligned with SyN in Fig.5 and with affine-only transformation in Fig.6, for 3 
illustrative purposes. 4 
? TROUBLESHOOTING 5 
  6 
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TROUBLESHOOTING  1 
See Table 3 for troubleshooting guidance 2 
 3 
ANTICIPATED RESULTS 4 
The CUBIC pipeline can be used for whole-organs or -body clearing. It is simple, 5 
efficient, and reproducible and thus can be applied to simultaneous multi-sample 6 
clearing in a single tube (Fig. 2c, inset) or a plastic container. The procedure can be 7 
performed using equipment usually used in a typical biology laboratory (Fig. 2a-d). By 8 
simple immersion of sample in reagent-1, clearing is obvious within several hours (Fig. 9 
2e) and such partially cleared samples are even applicable to deep region imaging with 10 
two-photon microscopy18. The CUBIC reagents also decolorize organs and the whole 11 
body by removing heme, which is also apparent just after CB-Perfusion (Fig. 3a and b), 12 
and this ability enables whole-body clearing within two weeks (Fig. 3c and d). We 13 
summarize the organs we have used CUBIC on in Table 1. Removal of the CUBIC 14 
reagents by PBS wash reverses the cleared state (Fig. 2e), but the tissue is clear again 15 
if re-immersed into CUBIC reagents. 16 
Fig. 4a-f shows typical imaging results for the Thy1-YFP-H Tg mouse brain at 17 
1.6× zoom. Overall, soma and other subcellular structures such as neurites in the 18 
mouse brain can be captured providing they are sparsely labeled (Fig. 4b, d, e, 19 
Supplementary Video 1). Other organs were also subjected to rapid, multi-color 3D 20 
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imaging in the same platform (Fig. 4g and h). Of note, these data were collected for 1 
approximately 30-60 min for each direction/color.  2 
According to the user’s experimental purpose, high or low resolution images 3 
may be acquired. We use relatively low resolution because our primary purpose is to 4 
analyze cells within the context of a whole organ or body in a high-throughput manner. 5 
However subcellular structures can be observed in the cleared tissue (Fig. 4b-f)18 and 6 
thus CUBIC permits more detailed observations with a higher zoom on the LSFM, or by 7 
using higher NA objective lenses on other confocal and two-photon microscopes .  8 
We implemented an image informatics method originally used in fMRI analysis 9 
to compare different brains. In this pipeline, the acquired dataset are preprocessed by 10 
merging D-V and V-D to make sure the resulting images are clear throughout the 11 
Z-stack (Fig. 5). Then signal subtraction between samples is calculated (Fig. 6). Here 12 
we show an example of Arc-dVenus Tg mouse brains with or without light stimuli18, 26 13 
(Fig. 6a). The raw images were preprocessed, aligned and normalized, and then 14 
subtraction of Venus signal was calculated to visualize light-responsive regions at the 15 
whole-brain scale (Fig. 6b-d). These calculations could be achieved by whole-organ 16 
counterstaining in the CUBIC clearing protocol. Note that the final resolution of images 17 
in this process is downscaled and it is more difficult to achieve ‘single-cell resolution’ 18 
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throughout the entire imaging field, due to the current software limitations. This will be 1 
addressed in future studies. 2 
 In summary, CUBIC provides a platform for comprehensive cell detection and 3 
analysis across whole organs and the body. Possible applications of CUBIC will be for 4 
whole-organ samples from multiple conditions or timepoints, detection of aberrant 3D 5 
morphological changes in diseased tissues or a scalable observation of 6 
tissue-to-subcellular structures in a single cleared organ. The method will therefore 7 
support organism-level systems biology and facilitate our understanding of complicated 8 
biological phenomena in multicellular organisms. 9 
  10 
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FIGURE LEGENDS 1 
Figure 1 2 
Overview of the CUBIC pipeline. CUBIC is composed of 3 major stages (clearing, 3 
imaging, and analysis). For efficient and reproducible clearing, we provide three 4 
protocols: 1) simple immersion (step 2A) which takes ~11 d in the case of a whole brain 5 
from an adult mouse (but varied according to the experimental purpose and organs), 2) 6 
CB-perfusion protocol for the whole adult mouse (step 2C), which takes ~14 d, 3) the 7 
CB-Perfusion and immersion hybrid protocol (step 2B) in which dissected organs after 8 
CB-Perfusion can be continuously cleared according to the simple immersion protocol. 9 
Rapid 3D imaging can be performed with an LSFM. The collected data is processed and 10 
analyzed, such as signal comparison between samples as described in this manuscript. 11 
Images of actual samples correspond to the samples in Fig. 2 and 3. All animal 12 
experiments here were approved by the Animal Care and Use Committee of the RIKEN 13 
Kobe Institute and The University of Tokyo, and all of the animals were cared in 14 
accordance with the Institutional Guidelines. 15 
 16 
Figure 2 17 
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Procedure of the simple immersion protocol. (a) Preparation of reagent-2. This reagent 1 
contains a high concentration of urea (25 wt%) and sucrose (50 wt%) (upper panel). 2 
These can be completely dissolved by heat and stirring with a microwave and a hot 3 
stirrer (lower panel). (b) A vacuum desiccator for the degas steps. (c) An incubator with 4 
shaker (a hybridization incubator) that we use for the clearing procedure. Inset: 5 brain 5 
samples treated with reagent-1 in a single tube (day 5). (d) A table shaker used for PBS 6 
washing step at room temperature. (e) Appearance of a brain sample in each step. A 7 
brain from C57BL/6 male mouse (8-week-old) was used. Reagent-1-treated sample is 8 
temporally swollen but the size is recovered after immersion in reagent-2. Scale bar: 5 9 
mm. All animal experiments here were approved by the Animal Care and Use 10 
Committee of the RIKEN Kobe Institute and The University of Tokyo, and all of the 11 
animals were cared in accordance with the Institutional Guidelines. 12 
 13 
Figure 3 14 
Procedure of the CB-Perfusion protocol. (a) Surgical setup for CB-Perfusion. The 15 
transcardiac perfusion line is connected to 1) heparin-PBS for flushing the blood, 2) 4% 16 
PFA on ice with peristaltic pump for fixation, 3) PBS for flushing PFA, and 4) 1/2-diluted 17 
reagent-1 for accelerative clearing through the vascular system. (b) Dissected organs 18 
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just after CB-Perfusion. Organs such as the pancreas, spleen or kidney are 1 
macroscopically cleared and decolored at this point. The clearance of these organs is 2 
indicative of how well researchers succeed in CB-Perfusion. Scale bar: 5 mm. (c) 3 
Clearing performance of CB-Perfused dissected organs at day 1 in reagent-1 and at day 4 
10 in reagent-2. CB-Perfused organs with a successful procedure are significantly 5 
transparent after 1 d of reagent-1 treatment. Some of the organs such as pancreas are 6 
more transparent in reagent-1 rather than in reagent-2. Scale bar: 5 mm. (d) Clearing 7 
performance of a CB-Perfused whole body just after CB-Perfusion and after two weeks 8 
of reagent-1 treatment. Organs such as pancreas, submaxillary gland and spleen tend 9 
quickly become transparent by CB-Perfusion. Major abdominal organs except bones 10 
and gastrointestinal content become sufficiently transparent after two weeks of 11 
reagent-1 treatment. C57BL/6 male mice (8-week-old) were used in (b)-(d). All animal 12 
experiments here were approved by the Animal Care and Use Committee of the RIKEN 13 
Kobe Institute and The University of Tokyo, and all of the animals were cared in 14 
accordance with the Institutional Guidelines. 15 
 16 
Figure 4 17 
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Whole-organ imaging with LSFM. (a) The microscope setup and the customized sample 1 
holder (inset) used in this manuscript.  (b) Left: a raw TIFF image (2560 × 2160) from a 2 
cleared Thy1-YFP-H Tg mouse brain34 (male, 23-week-old) (imaging conditions: Z = 10 3 
μm step × 749 planes, zoom = 1.6×, expose = 50 ms × two illuminations from each side, 4 
total acquisition time = about 30 min). The sample was cleared according to the 5 
immersion protocol in this manuscript. Right: a magnified image of the indicated area in 6 
the left panel. These images were minimally processed (sharpness, brightness and 7 
contrast) with ImageJ. (c) The reconstituted 3D image of the acquired data in b. A View 8 
from dorsal side is shown. (d) A magnified image of the indicated area in c. (e) A 9 
magnified image of the right hippocampus, viewed from the midline to lateral, as 10 
indicated in c.  (f) A magnified image of the reconstituted X-Z image of the right 11 
hippocampus, as indicated in c. (g) The reconstituted 3D whole-organ images from 12 
β-actin-nuc-3×mKate2 KI mouse19 (male, 8-week-old) (imaging condition: Z = 20 μm 13 
step × 350-500 planes, zoom = 0.8×-1.6×, expose = 100 ms to 2 s × two illuminations 14 
from each side, total acquisition time = about 45 min). The samples were cleared and 15 
stained with SYTO 16 according to the CB-Perfusion protocol. The magnified images of 16 
SYTO 16, mKate2, and merged signals at the approximate 1 mm depth of each organ 17 
(zoom = 5×). (h) The reconstituted 3D whole-organ images from a CAG-EGFP Tg35 18 
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stained with PI (male, 8-week-old) (imaging condition: Z = 20 μm step × 350-500 planes, 1 
zoom = 0.8×-1.6×, expose = 100 ms to 2 s × two illuminations from each side, total 2 
acquisition time = about 45 min). The samples were cleared and stained with PI 3 
according to the CB-Perfusion protocol. Brightness/contrast and minimal gamma-value 4 
of images in c-h were adjusted with Imaris. All animal experiments here were approved 5 
by the Animal Care and Use Committee of the RIKEN Kobe Institute and The University 6 
of Tokyo, and all of the animals were cared in accordance with the Institutional 7 
Guidelines. 8 
 9 
Figure 5 10 
Preprocessing of acquired 3D image for comparison analysis. Here we use the dataset 11 
of the Thy1-YPF-H Tg mouse brain acquired in ref. 18 as an example. “Collect raw 12 
images” panel shows the scheme of brain 3D imaging of two different directions (D-V 13 
and V-D). Raw TIFF images (here only YFP channel shown) in the panel are Z = 2.25 14 
mm (sharp) and 5.5 mm (blurred) for upper and lower panels, respectively. The raw 15 
dataset are downscaled to 25% and converted to NIfTI-1 files (shown as capture 16 
images of ITK-SNAP). Then, structural D-V data (shown as reconstituted 3D images) 17 
via nuclei counterstaining are registered to the corresponding V-D data. This step is to 18 
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calculate transformation parameters, which is applied to the signal D-V data in the 1 
following step (alignment). We then merge the aligned images in order to ensure 2 
sharpness throughout the resulting 3D image (YFP channel is shown as an example 3 
again). To do so, the “edge content” based on the Prewitt operator is calculated for both 4 
D-V and V-D images. This is used to define two threshold values at Z slice position n 5 
and m and to create the merged composite NIfTI-1 image (shown as capture images of 6 
ITK-SNAP) according to these values.  7 
The reconstituted 3D images and plane images in the “Align” and “Combine” panels 8 
were prepared by using exported TIFF images from the corresponding NIfTI-1 data. 3D 9 
reconstitutions were performed with Imaris software as in Fig. 4, and shown as views 10 
from dorsal and ventral side in D-V and V-D images, respectively. All animal 11 
experiments here were approved by the Animal Care and Use Committee of the RIKEN 12 
Kobe Institute and The University of Tokyo, and all of the animals were cared in 13 
accordance with the Institutional Guidelines. 14 
 15 
Figure 6 16 
Calculation of signal subtraction. (a) Here we use the dataset of the Arc-dVenus Tg 17 
mouse brains with or without light stimuli, acquired in ref. 18 as an example (Z = 10 μm 18 
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step × 625~675 planes, zoom = 2×, expose = 3 s × two illuminations for Venus and 300 1 
ms × two illuminations for PI, respectively). The reconstituted 3D images from raw TIFF 2 
stacks are shown as views from dorsal and ventral sides in D-V and V-D images, 3 
respectively. Yellow, Venus. Blue, PI. (b) We first preprocess these datasets as in Fig. 5. 4 
Then, we align one dataset, Light (+), to the other, Light (-), by registering the first 5 
structural data to the second (internal reference). The internal reference is also 6 
registered to a brain atlas such as the Allen Brain Atlas. All images are then aligned to 7 
the atlas and normalized. The 3D reconstituted images from NIfTI-1 data for structure 8 
and signal of Light (+) or (-) samples, after alignment to the internal reference (step 1 in 9 
the panel), are shown as dorsal side view. (c) Reconstituted 3D images of aligned and 10 
normalized Venus channel (yellow) and aligned PI channel (blue) images from the 11 
corresponding NIfTI-1 data. Views from dorsal side are shown. (d) Results of subtraction, 12 
shown as 3D reconstituted images. Views from dorsal side (left and upper right) and 13 
dorsolateral side (lower right) are shown. Signals observed in Light (+) or (-) conditions 14 
are shown in magenta and right blue, respectively. Standardized PI signals of Light (+) 15 
sample are merged and indicated in blue. As seen in the magnified panel (upper right), 16 
single cells in the sparsely labeled regions can be detected even in the downscaled 17 
images.  18 
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The reconstituted 3D images in (b)-(d) were prepared by using exported TIFF images 1 
from the corresponding NIfTI-1 data and with Imaris software as in Fig. 4 and 5. All 2 
animal experiments here were approved by the Animal Care and Use Committee of the 3 
RIKEN Kobe Institute, the Gifu University and The University of Tokyo, and all of the 4 
animals were cared in accordance with the Institutional Guidelines. 5 
  6 
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TABLE 1 | Tissues CUBIC has been successfully applied to. 
Tissue Clearing protocol 
Reagent 
before 
imaging 
Clearing 
efficiency 
Mouse whole body*19 CB-Perfusion Reagent-1†† Good 
Mouse brain18, 19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Marmoset hemisphere**18 Simple immersion Reagent-2 Good 
Mouse heart19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse lung19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse spleen19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse liver19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse stomach19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse intestine19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse kidney19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse pancreas19 Simple immersion 
/ CB-Perfusion 
Reagent-2 or 
Reagent-1 
Good 
Mouse lymph node† Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse muscle19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse skin***19 Simple immersion 
/ CB-Perfusion 
Reagent-2 Good 
Mouse bone19 CB-Perfusion Reagent-1 Partially cleared 
but need further 
investigations†††
Tissues with melanin (eye and hair)19 CB-Perfusion - Not cleared with 
the current 
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reagents 
*We performed imaging of postnatal day-1 samples19. Imaging of cleared adult mouse was not 
tested due to size limitation of current LSFM setup. 
**So far we tested a brain sample of postnatal day-3. Adult brain will be tested in future studies. 
***Need hair removal 
†Unpublished result 
††The cleared body specimen can be stocked in the reagent. 
†††Bone clearing of infant mice was sufficient for imaging19 
 
 
TABLE 2 | Other clearing methods and their applications to imaging and analysis 
Methods 
Chemical 
contents 
Applied imaging 
methods 
Applied computational 
analysis methods 
CUBIC18, 19 Quadrol / 
Triethanolamine / 
Triton X-100 / 
Urea / Sucrose 
 
Ultramicroscope 
(LSFM), 
Two-photon 
microscopy, 
Confocal 
microscopy 
Whole-brain signal 
comparison analysis, 
Extraction of anatomical and 
histological structures, 
Quantitative analysis of 
pancreatic Langerhans islets 
 
3DISCO4, 5, 7, 36-38 Ethanol or 
Methanol / 
Xylene / Benzyl 
alcohol / Benzyl 
benzoate for 
BABB method 
 
Tetrahydrofuran / 
Dichloromethane 
/ Dibenzyl ether 
for THF-DBE 
method 
 
Ultramicroscope 
(LSFM),  
Two-photon 
microscopy, 
Confocal 
microscopy 
3D reconstruction, 
Visualization of intensities, 
Axon tracing, Cell number 
quantification, Tumor volume 
calculation 
Scale9 Urea / glycerol / 
Triton X-100 
 
Two-photon 
microscopy, 
Confocal 
microscopy 
 
3D reconstruction, Distance 
measurement 
SeeDB10 D(-)-Fructose / 
α-thioglycerol 
Two-photon 
microscopy, 
Confocal 
microscopy 
3D reconstruction, Axon and 
dendrite tracing, Cell 
distribution analysis 
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FRUIT14 D(-)-Fructose / 
urea 
Two-photon 
microscopy 
 
 
ClearT11 Formamide for 
ClearT,  
Formamide and 
polyethylene 
glycol for ClearT2 
 
Optical Sectioning 
Microscopy, 
Stereomicroscopy 
 
2,2'-Thiodiethanol1
2, 13 
2,2'-Thiodiethan
ol 
Two-photon 
microscopy, 
Confocal 
microscopy, 
Two-photon serial 
sectioning 
tomography 
 
3D reconstruction 
CLARITY and 
related methods*13, 
15-17 
SDS in borate 
buffer / one of 
FocusClearTM, 
RIMS (Histodenz 
or Sorbitol), or 
2,2'-Thiodiethan
ol 
Confocal 
microscopy, 
Two-photon 
microscopy, COLM 
and other custom 
LSFM 
3D reconstruction, Neurite 
tracing  
*Use acrylamide-embedded specimen 
 
 
 
 
TABLE 3 | Troubleshooting table.  
Step Problem Possible reason Possible solution 
Preparation 
(REAGENT 
SETUP) 
Possible 
degradation of 
chemicals in 
CUBIC reagents 
 
Too much heating 
(which causes 
ammonia odor) 
Milder and shorter heating 
during preparation 
 Precipitate in 
reagent-2  
Lower room 
temperature, 
particularly in 
winter 
 
Prepare the reagent before 
use; heat with microwave for 
5-10 s (avoid boiling) 
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Fixation 
(Steps 2A(i) and 
2B(iii)) 
 
Poor PFA 
perfusion  
Insufficient cooling 
of PBS and PFA 
Keep PBS and PFA on ice just 
before perfusion 
  Wrong position of 
the tip of needle 
Make sure that the tip of 
needle is in the left ventricle of 
the heart 
 
  Insufficient 
pressure for 
perfusion 
Make sure perfusion outlet only 
occurs at the cut in the liver 
 
 
Clearing 
(Steps 2A(iv-viii), 
2B(v-ix) and 
2C(iii)) 
 
Poor organ 
clearing during 
reagent-1 
Alkaline pH of PFA Adjust pH of PFA to 
approximately 7.4 
  Too much fixation 
time 
 
Stop post-fixation within 24 h 
  Insufficient 
incubation time, 
reagent amount or 
mixing 
Incubate longer in reagent-1 (a 
few days more); Exchange 
reagent-1 more frequently 
(every day rather than every 2 
d); Shake or rotate 
appropriately 
 
  Use of an aged 
animal 
 
Use a younger animal 
  Organ-dependent 
differences in 
clearing 
Use reagent-1 rather than 
reagent-2 for the final clearing 
reagent (e.g. pancreas 
becomes clearer in the 
reagent-1, see Fig. 3) 
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 Excess shrinkage 
or deformation of 
cleared organ after 
reagent-2 
Inappropriate 
concentration of 
salt whilst treating 
with 1/2 reagent-2 
If shrunk too much, decrease 
the concentration of PBS in the 
1/2 reagent-2 (e.g. mix 1:1:2 of 
distilled water:PBS:reagent-2 
rather than 1:1 mix of 
PBS:reagent-2); usage of 1/2 
reagent-2/water instead of PBS  
causes swelling 
 
  Incubation at 37°C Try to incubate samples at 
room temperature during 
reagent-2 steps (takes more 
time) 
 
  Insufficient 
replacement in 1/2 
reagent-2 
 
Sufficiently incubate in the 
reagent for complete 
replacement 
  Use of an 
infant/juvenile 
animal 
Organs from an infant/juvenile 
animal tend to shrink more in 
reagent-2 and need less 
incubation time during 
reagent-1 treatment 
 
  Use of samples 
prepared in 
CB-Perfusion 
 
Try simple immersion protocol 
 Poor organ 
clearing during 
reagent-2 
Incomplete 
dissolution or 
precipitate in 
reagent-2 
 
Make sure no precipitate exists 
in the prepared/stocked 
reagent-2 
  Insufficient 
incubation in 
reagent-1 
Increase reagent-1 treatment 
time 
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  Insufficient 
replacement into 
reagent-2 
Make sure to incubate at 37°C 
during reagent-2; Use more 
volume of reagent-2 and 
exchange the reagent one or 
two more times 
 
 Ammonia smell 
during clearing 
 
Degradation of 
urea 
Change the fresh media, and 
avoid too much heating during 
preparation of reagents 
 
 Bubbles on inside 
structures of 
organs (e.g. brain 
ventricles) after 
reagent-2 
 
Insufficient degas Degas the reagent-2 after 
preparation; Degas the sample 
in a limited volume of PBS 
before the reagent-2 
incubation 
  Rotation during 
reagent-2 
Incubate in the reagent-2 with 
gentle shaking rather than 
rotation 
 
 Tissue damage on 
freezing 
Keeping the 
sample at -20°C ~ 
-30°C (which 
possibly causes 
growth of water 
crystals inside the 
tissue) 
 
Stock the sample in O.C.T. 
compound at –80°C; Thaw the 
sample gradually at room 
temperature 
  Insufficient 
replacement by 
sucrose solution 
 
Increase incubation time in the 
sucrose solution (i.e. until 
organs sink) 
Imaging  
(Step 6) 
Floating sample 
during imaging 
Usage of 
reagent-2 rather 
Immerse the sample in oil 
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than the immersion 
oil mix 
 
 Bubble on the 
surface 
Insufficient 
removal of the 
reagent-2 
Remove excess reagent-2 
before immersion into the oil 
mix; Remove bubbles in the oil 
with a needle or a tapered 
forceps 
 
 High 
auto-fluorescence 
Insufficient 
fluorescent signal 
Select a bright fluorescent 
protein (e.g. YFP, Venus) with 
a strong expression promoter 
(e.g. CAG); Avoid green 
channel and use a red 
fluorescent protein (e.g. 
mKate2) 
 
  Alkaline pH of PFA Adjust pH of PFA to 
approximately 7.4 
 
  Use of an aged 
animal 
 
Use a younger animal 
 Weak or 
non-detectable 
fluorescence 
 
Insufficient 
fluorescent signals 
Select a bright fluorescent 
protein with a strong 
expression promoter as above 
  Signal decrease in 
CB-Perfusion 
Use more PFA for perfusion 
and pause the perfusion 
procedure after PFA perfusion 
to increase fixation reaction (3 
h~); Try the immersion 
protocol; Select an animal 
strain with a bright fluorescent 
signal 
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  Temperature 
during clearing 
Higher temperature during 
clearing may decrease 
fluorescence signals8. Try to 
incubate at room temperature 
rather than 37°C. (Note that 
lower temperature also 
decreases clearing efficiency) 
 
  Inappropriate 
setting of 
microscopy 
 
Check the setting of laser 
power, filter and exposure time 
 Poor Z resolution Inappropriate 
setting of 
light-sheet focus 
Adjust the light-sheet focus to 
the region of interest (in the 
case of LaVision 
Ultramicroscope, the width of 
focused sheet is 1/3-1/4 of an 
adult mouse hemisphere and 
thus it is impossible to take 
images with adjusted focus 
throughout the brain) 
 
Analysis  
(Steps 8-15) 
Brain appears 
deformed in the 
NIfTI-1 file (Step 8) 
Wrong scaling Check the parameter file and 
ensure that the correct voxel 
dimensions are given (for the 
raw TIFF image, in mm) 
 
 Incorrect brain 
orientation (Step 8) 
Different brain 
position during 
imaging 
  
Reorient the NIfTI-1 file in 
ITK-SNAP until it matches your 
raw TIFF stack. Note the 
correct orientation (e.g. RPS) 
and edit the convertTiffFiles.py 
script accordingly (line 148 for 
DV-acquired files, line 150 for 
VD-acquired ones) 
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 Error message: 
"No such file or 
directory" 
Wrong folder name 
or brain ID in the 
parameter file 
Check the parameter file for 
that step and ensure that all 
brain IDs are valid and that all 
folders exist 
 
 
 Error message: 
"Command not 
found" 
Missing software Make sure that all the required 
tools are installed, that they are 
accessible from the command 
line, and that our two C++ 
programs are compiled 
 1 
  2 
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